SWK Holdings

SWK Holdings FCF per Share

Delisted

The Free Cash Flow per Share of SWK Holdings (SWKH) as of Nov 4, 2026 is 2.20 USD. In the previous year, Free Cash Flow per Share was 1.84 USD — a change of 19.64% (higher).

FCF per Share

2.20USD

YoY

19.64%

Last updated:

Free Cash Flow per Share of SWK Holdings is 2025 2.20 USD. Free Cash Flow per Share of SWK Holdings was 2024 1.84 USD. It decreases by 19.64% higher compared to the previous year.

The SWK Holdings FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
1.52 USD
Jan 1, 2019
1.43 USD
Jan 1, 2020
1.20 USD
Jan 1, 2021
2.58 USD
Jan 1, 2022
0.61 USD
Jan 1, 2023
1.15 USD
Jan 1, 2024
1.84 USD
Jan 1, 2025
2.20 USD
The SWK Holdings FCF per Share history
YEARFCF per ShareYoY
2.20USD+19.64%
1.84USD+59.80%
1.15USD+88.07%
0.61USD-76.30%
2.58USD+115.84%
1.20USD-16.41%
1.43USD-5.60%
1.52USD+2.02%
1.49USD+102.67%
0.73USD-13.68%
0.85USD+115.67%
0.39USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SWK Holdings Stock analysis

What does SWK Holdings do? SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company was founded in 1996 and is headquartered in Dallas, Texas. Its business model focuses on investing capital in companies developing innovative technologies in the life sciences field. SWK Holdings Corp supports its portfolio companies with capital and resources to promote their growth and development. The company offers a wide range of products and services, including financing and investment services, business development, and consulting. It focuses on financing companies in various areas, including biotechnology, medical devices, and pharmaceuticals. SWK Holdings Corp specializes in various segments within the life sciences field, including cancer, autoimmune diseases, dermatology, ophthalmology, neurology, orthopedics, and cardiology. It also invests in companies developing therapeutics and diagnostics for rare diseases. Over the years, SWK Holdings Corp has gained a strong reputation in the industry through its investments in a variety of companies and technologies. The company is known for its ability to quickly and flexibly respond to changing market trends and conditions. It takes pride in being a responsible company that adheres to ethical business practices and supports the community and environmental protection. SWK Holdings Corp also strives to find opportunities to reduce its ecological footprint. In summary, SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company has a reputation for its ability to quickly and flexibly respond to changing market trends and conditions. It offers a wide range of products and services and specializes in various segments within the life sciences field. SWK Holdings Corp is a responsible company committed to adhering to ethical business practices and supporting the community and environmental protection. SWK Holdings is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SWK Holdings stock

Free Cash Flow per Share of SWK Holdings is 2.20 USD in 2025.

Free Cash Flow per Share of SWK Holdings changed from 1.84 USD to 2.20 USD, representing a 19.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share SWK Holdings since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — SWK Holdings

All Key Metrics — SWK Holdings